Porphyria and Porphirins Abstracts - European Porphyria Network

Search Results

Check all

Abstracts
Selected	Titles
	DIFFERENTIATION BETWEEN SPORADIC AND FAMILIAL PORPHYRIA CUTANEA TARDA – (volume 52-2003) *Aarsand AK¹, Brun A¹, Boman H², Sandberg S¹*
	WITHIN-SUBJECT BIOLOGICAL VARIATION OF THE URINARY EXCRETION OF ALA, PBG AND PORPHYRINS IN ACUTE INTERMITTENT PORPHYRIA – (volume 52-2003) *Aarsand AK¹, Petersen PH², Sandberg S¹*
	TIN MESOPORPHYRIN POTENTIATION OF HEME THERAPY: A DOSE-RANGING STUDY IN ASYMPTOMATIC PORPHYRIA – (volume 52-2003) *Anderson KE, Kormos-Hallberg C*
	MYELOPROLIFERATIVE DISEASE COMPLICATED BY LATE-ONSET ERYTHROPOIETIC PROTOPORPHYRIA AND LIVER DISEASE – (volume 52-2003) *Badminton MN¹, Whatley SD¹, Goodwin RG², Kell J³, Laidler P⁴, Long CC², Burnett AK³, Elder GH¹*
	ACQUIRED PORPHYRIA CUTANEA TARDA PROBABLY RELATED TO ANTINEOPLASTIC THERAPY IN A PATIENT AFFECTED BY CHRONIC MYELOID LEUKAEMIA – (volume 52-2003) *Barbieri L, Griso D, Sorge F, Usai G, Macri A, Biolcati G*
	MISCARRIAGE DUE TO RECURRENT ACUTE PORPHYRIC ATTACKS DURING PREGNANCY IN A PATIENT WITH ACUTE INTERMITTENT PORPHYRIA – (volume 52-2003) *Bartz C¹, Poblete-Gutiérrez P², Kunitz O³, Wiederholt T², Merk Hf⁴, Rath W¹, Frank J⁵*
	FUNCTIONALIZED CALIX[4]PHYRINS: EFFICIENT ACCESS TO UNEXPECTED PORPHOMONO- AND PORPHODIMETHENES – (volume 52-2003) *Bernátková M¹,², Andrioletti B¹, Rose E¹, Král V²*
	HOMOZYGOUS VARIEGATE PORPHYRIA. FIRST ITALIAN CASE – LONG TERM FOLLOW UP – IDENTIFICATION OF NOVEL MUTATIONS IN PPOX GENE – (volume 52-2003) *Bonuglia M, D’amato M, Sorge F, Griso D, Macri A, Biolcati G*
	GENETIC SCREENING OF ACUTE INTERMITTENT PORPHYRIA IN HUNGARY: AN UPDATE – (volume 52-2003) *Bor M¹, Balogh K², Berkes E², Székely E¹, Pusztai Á¹, Tasnádi Gy¹, Hunyady L²*
	THE NORDIC DRUG DATABASE FOR ACUTE PORPHYRIA – (volume 52-2003) *Brun A¹, Pomp E¹, Thunell S²*
	NON-PORPHYRIC SKIN DISEASE IN THE PORPHYRIAS – (volume 52-2003) *White J, Creamer D, Peters TJ*
	IDENTIFICATION OF A RECURRENT MUTATION IN THE PORPHOBILINOGEN DEAMINASE GENE IN GERMAN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA – (volume 52-2003) *Wiederholt T¹, Poblete Gutiérrez P¹, Gardlo K², Bolsen K², Merk HF³, Frank J⁴*
	A NEW VARIANT OF ERYTHROPOIETIC PROTOPORPHYRIA WITH NORMAL FERROCHELATASE ACTIVITY – (volume 52-2003) *Wilson J.H.P., Edixhoven-Bosdijk A., Koole-Lesuis R., Kroos M.J., de Rooij F.W.M.*
	NEUROPSYCHIATRIC PORPHYRIA IN PATIENTS WITH REFRACTORY EPILEPSY: REPORT OF THREE CASES – (volume 52-2003) *Winkler AS¹, Peters TJ², Elwes RDC¹*
	ERYTHROCYTE AND LIVER PORPHOBILINOGEN DEAMINASE ACTIVITY IN CIRRHOSIS AND CLINICAL OR EXPERIMENTAL CHOLESTASIS – (volume 52-2003) *Yalouris A, Manganas D, Yannakos G, Triantafyllou G, Danias P, Kantartzis K, Raptis S*
	MODIFICATION OF GRISEOFULVIN-INDUCED PORPHYRIA BY THE DEVELOPMENT OF EXPERIMENTAL DIABETES MELLITUS – (volume 52-2003) *Yalouris A¹, Grigoriadou M², Marakomichelakis G², Diamantopoulos E², Raptis S¹*
	EFFECTS OF ISOFLURANE ON HEME SYNTHESIS IN A MOUSE MODEL FOR ERYTHROPOIETIC PORPHYRIA – (volume 52-2003) *Buzaleh A.M.¹, Navarro S.², García-Bravo M.², Morán-Jiménez M.J.², Batlle A.¹, Enriquez De Salamanca R.², Fontanellas A.²*
	PORPHYRINS STATUS IN SPONTANEOUSLY HYPERTENSIVE RATS – (volume 52-2003) *Caballero F.A., Guolo M.N., Batlle A*
	IN VITRO AND IN VIVO USE OF ALA DERIVATIVES TO OPTIMISE PHOTODYNAMIC THERAPY – (volume 52-2003) *Casas A.G.¹, Perotti C¹, Di Venosa G.¹, Fukuda H.¹, Sacca P.¹, Macrobert A.², Batlle A.¹*
	URINARY STEROID HORMONE METABOLITES IN PATIENTS WITH PORPHYRIAS – (volume 52-2003) *Christakoudi S, Taylor Nf, Deacon Ac, Peters Tj*
	ASSOCIATION BETWEEN THALASSEMIA MAJOR AND PORPHYRIA CUTANEA TARDA TYPE I – (volume 52-2003) *Cianciulli P¹, Barbieri L², Macri A², Griso D², Sorrentino F¹, Sorge F², Gerolamo U², Biolcati G²*
	GENETIC ANALYSIS OF VARIEGATE PORPHYRIA IN ITALY: IDENTIFICATION OF EIGHT NOVEL MUTATIONS IN THE PROTOPORPHYRINOGEN OXIDASE GENE – (volume 52-2003) *D’amato M, Bonuglia M, Barile S, Griso D, Macri A, Sorge F, Biolcati G*
	EXAMINATION OF THE ACTIVE SITE OF HUMAN FERROCHELATASE – (volume 52-2003) *Dailey H.A., Wu C.-K., Horanyi P., Missaoui W.*
	VISUALISATION OF PROTOPORPHYRINOGEN OXIDASE MITOCHONDRIAL TARGETING USING GREEN FLUORESCENT PROTEIN – (volume 52-2003) *Davids L.M., Corrigall A.V., Meissner P.N.*
	GENOTYPE-PHENOTYPE RELATIONSHIPS IN FAMILIES WITH ERYTHROPOIETIC PROTOPORPHYRIA – (volume 52-2003) *De Rooij F.W.M., Koole-Lesuis R., Edixhoven-Bosdijk A., Kwaspen F.A.M., Van Den Bosch J.B., Kroos M., Wilson J.H.P.*
	GENE TRANSFER INTO HUMAN HEMATOPOIETIC STEM CELLS. APPLICATION TO THE GENE THERAPY OF CONGENITAL ERYTHROPOIETIC PORPHYRIA – (volume 52-2003) *de Verneuil H , Geronimi F, Robert E, Vernhet I, Ged C, Richard E, Moreau-Gaudry F*
	EUROPEAN PORPHYRIA INITIATIVE (EPI) – (volume 52-2003) *J.C. Deybach¹, M. Badminton², G. Elder², J. Frank³, P. Martásek⁴, E. Minder⁵, S. Parker⁶, H. Puy¹, S. Sandberg⁷*
	TWO NOVEL MOLECULAR DEFECTS IN FERROCHELATASE GENE IN ITALIAN PATIENTS WITH ERYTHROPOIETIC PROTOPORPHYRIA – (volume 52-2003) *Di Pierro E., Moriondo V., Deponti D., Fiorelli G., Cappellini M.D.*
	COINHERITANCE OF A MUTATION IN PPOX GENE AND AN INTRONIC MUTATION IN HMBS GENE CAUSES A SEVERE PORPHYRIA’S PHENOTYPE – (volume 52-2003) *Di Pierro E., Roselli E., Patti E., Danielli G., Cappellini M.D.*
	THE THIRD CASE OF DOSS PORPHYRIA IN GERMANY – (volume 52-2003) *Doss M.O.¹, Stauch T.², Groß U.³, Renz M.², Akagi R.⁴, Doss-Frank M.¹, Seelig H.P.², Sassa S.⁴*
	RESIDUAL ACTIVITY OF HUMAN PORPHOBILINOGEN DEAMINASE WITH R167Q OR R167W MUTATIONS: AN EXPLANATION FOR SURVIVAL OF HOMOZYGOUS AND COMPOUND HETEROZYGOUS ACUTE INTERMITTENT PORPHYRICS – (volume 52-2003) *Edixhoven-Bosdijk A., De Rooij F.W.M., Baars-Heesakkers E., Wilson J.H.P.*
	A HIGHLY SENSITIVE AND SPECIFIC METHOD FOR THE MEASUREMENT OF THE I AND III ISOMERS OF PORPHYRINS IN PLASMA – (volume 52-2003) *Erlandsen E.J., Markussen S., Brock A.*
	5-AMINOLEVULINATE SYNTHASE: MODULATION OF THE COFACTOR CHEMISTRY BY THE PROTEIN SCAFFOLD – (volume 52-2003) *Ferreira G.C.*
	NOVEL MUTATION IN PORPHOBILINOGEN DEAMINASE GENE IN A FAMILY WITH ACUTE INTERMITTENT PORPHYRIA FROM NEPAL – (volume 52-2003) *Flachsová E.¹, Verma I.C.², Zeman J.¹, Raman C.S.³, Martásek P.¹*
	INVENTORY OF MUTATIONS CAUSING PORPHYRIA IN SWEDEN – (volume 52-2003) *Floderus Y., Wiman A., Harper P.*
	PORPHYRIA CUTANEA TARDA AND HAEMOCHROMATOSIS – (volume 52-2003) *Garaczi E., Kószó F., Oláh J., Morvay M., Dobozy A.*
	SUCCESSFUL AND SAFE TREATMENT OF HYPERTRICHOSIS BY HIGH-INTENSITY PULSES OF NON-COHERENT LIGHT IN A PATIENT WITH HEPATOERYTHROPOIETIC PORPHYRIA – (volume 52-2003) *García-Bravo M¹, López-Gómez S², Segurado-Rodríguez MA², Morán-Jiménez MJ¹, Méndez M¹, Enríquez de Salamnca R¹, Fontanellas A¹*
	EXTENSIVE ANALYSIS OF A FAMILY WITH CONGENITAL ERYTHROPOIETIC PORPHYRIA ABSENCE OF CLINICAL MANIFESTATIONS IN AN HOMOZYGOUS MUTANT SIBLING – (volume 52-2003) *Ged C¹, Megarbane H², Chouery E³, Megarbane A³, De Verneuil H¹*
	FERROCHELATASE ALLELIC VARIANTS AND CLINICAL MANIFESTATION OF ERYTHROPOIETIC PROTOPORPHYRIA – (volume 52-2003) *Gouya L, Puy H, Robreau Am, Lamoril J, Da Silva V, Grandchamp B, Deybach Jc*
	ROLE OF THE WILD-TYPE ALLELE IN THE PENETRANCE OF DOMINANT ACUTE HEPATIC PORPHYRIAS – (volume 52-2003) *Gouya L., Puy H., Robreau A.M., Da Silva V., Deybach J.C.*
	QUALITY OF LIFE IN CONGENITAL ERYTHROPOIETIC PORPHYRIA: LONG-TERM FOLLOW-UP OF THREE DIFFERENT CASES – (volume 52-2003) *Griso D¹, Barbieri L¹, Barile S¹, Sorge F¹, Usai U¹, Morreale G², Cappelli B², Lanino E², Macri A¹, Biolcati G¹*
	ACUTE INTERMITTENT PORPHYRIA (A.I.P): A MULTIDISCIPLINARY APPROACH – (volume 52-2003) *Guida Cc¹, Pileri M², Garrubba M², Potenza A³, Caravella M⁴,Stallone C¹*
	CORRELATION BETWEEN PLASMA AND URINARY LEVELS OF PORPHOBILINOGEN (PBG) AND 5-AMINOLEVULINIC ACID (ALA) IN TEN ASYMPTOMATIC GENE CARRIERS OF ACUTE INTERMITTENT PORPHYRIA (AIP) WITH INCREASED PORPHYRIN PRECURSOR EXCRETION – (volume 52-2003) *Harper P¹, Floderus Y¹, Andersson C², Möller C², Rejkjaer L³, Sardh E⁴, Andersson D.E.H⁴*
	ACUTE INTERMITTENT PORPHYRIA IN CATALONIA (SPAIN) – (volume 52-2003) *Herrero C, To-Figueras J, Ingelmo M, Oliva R, Munoz C, Munoz E, Carreras C*
	– (volume 52-2003) *Hift RJ¹, Davidson BP¹, Van Der Hooft C², Meissner PN¹*
	TWO COURSE ILLUMINATING SCHEME IMPROVES AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY IN CELL CULTURES – (volume 52-2003) *Hinnen P., Siersema P.D., Edixhoven-Bosdijk A., Wilson J.H.P., De Rooij F.W.M*
	NON-REDUNDANT ROLES FOR HemZ AND HemF IN MAMMALIAN HEME BIOSYNTHESIS – (volume 52-2003) *Hunt R.D.¹, Bodnárová M.², Mikula I.², Chinenov Y.³, Martásek P², Raman C.S.¹*
	REGULATION OF HEME OXYGENASE-1 GENE EXPRESSION VIA MAP KINASE SIGNALING PATHWAYS IN THE LIVER – (volume 52-2003) *Immenschuh S¹, Kietzmann T²*
	CORRECTION OF THE BIOCHEMICAL DEFECT IN PORPHOBILINOGEN DEAMINASE DEFICIENT CELLS BY NON-VIRAL GENE DELIVERY – (volume 52-2003) *Johansson A¹, Möller C², Harper P¹*
	VALIDATION OF A DENATURING HPLC ASSAY FOR MUTATION ANALYSIS IN THE HUMAN PROTOPORPHYRINOGEN OXIDASE GENE – (volume 52-2003) *Käehne M¹, J.C. Deybach², Puy H², Robreau A-M², Viborg D¹, Petersen Ne¹*
	A STUDY OF THE POSSIBLE ROLE OF LOW EXPRESSED FUNCTIONAL PPOX ALLELES IN THE VARIABLE PENETRANCE OF VARIEGATE PORPHYRIA – (volume 52-2003) *Kimberg M, Warnich L*
	ON THE RELATIONSSHIP BETWEEN PORPHYRIA CUTANEA TARDA AND OTHER COMMON METABOLIC DISEASES (DIABETES, HYPERCHOLESTERINAEMIA) – (volume 52-2003) *Koch A.¹, Köstler E.¹, Stölzel U.², Wollina U.¹*
	PORPHYRIA CUTANEA TARDA (PCT) AND STEATOSIS HEPATIS – (volume 52-2003) *Koch A.¹, Köstler E.¹, Stölzel U.², Wollina U.¹*
	REGULATION OF 5-AMINOLEVULINATE SYNTHASE-1 BY GLUCOSE AND HEME – (volume 52-2003) *Kolluri S¹, Sadlon Tj², Bonkovsky H¹*
	THERAPEUTIC MONITORING OF PORPHYRIA CUTANEA TARDA (PCT) USING SERUM HAEMOPEXIN – (volume 52-2003) *Köstler E.K.¹, Stölzel U.², Hochmann G.H.¹, Doss M.O.D.³, Wollina U.¹*
	NOVEL OLIGOPYRROLIC MACROCYCLES AND PORPHYRIN DERIVATIVES: SYNTHESIS AND MEDICINAL APPLICATION – (volume 52-2003) *Král V.¹, Andrioletti B.², Rose E.², Dolenský B.¹, Kroulík J.¹, Bernátková M.¹, Cígler P.¹, Hub M.¹, Sinica A¹, Králová J³*
	NOVEL PORPHYRIN AND EXPANDED PORPHYRIN DERIVATIVES WITH CAPACITY TO INDUCE APOPTOSIS IN VARIOUS TUMOR CELLS FOLLOWING PHOTODYNAMIC TREATMENT – (volume 52-2003) *Králová J.¹, Král V.², Dvorák M.¹, Sinica A.², Vašek P.², Cígler P.², Volka K.², Sessler J.L.³, Poucková P.⁴, Valík M.²*
	ALTERATIONS OF PORPHYRIN METABOLISM IN MICE BY GRISEOFULVIN – (volume 52-2003) *Laftah A, Simpson Rj, Deacon A, Peters Tj*
	FLUOROMETRIC MEASUREMENT OF 5-AMINOLEVULINIC ACID IN SERUM – (volume 52-2003) *Lee C¹, Goeger De², Qiao X¹, Anderson Ke¹*
	IRON METABOLISM IN ERYTHROPOIETIC PROTOPORPHYRIC MOUSE MODEL – (volume 52-2003) *Lyoumi S.¹, Abitbol M.², Gouya L.¹, Andrieu V.³, Da Silva V.¹, Beaumont C.¹, Deybach J.C.¹, Puy H.¹*
	ERYTHROPOIETIC PROTOPORPHYRIA: A RAPID METHOD TO DETECT ASYMPTOMATIC GENE CARRIERS – (volume 52-2003) *Macri A, Barile S, Gerolamo U, Barbieri B, Sorge F, Griso D, Biolcati G*
	KINETIC AND PHYSICAL CHARACTERISATION OF RECOMBINANT WILD TYPE AND MUTANT HUMAN PROTOPORPHYRINOGEN OXIDASES – (volume 52-2003) *Maneli MH¹, Corrigall AV¹, Davids LM¹, Klump H², Kirsch RE³, Meissner PN¹*
	KINETIC AND PHYSICAL CHARACTERISATION OF RECOMBINANT WILD TYPE AND MUTANT HUMAN PROTOPORPHYRINOGEN OXIDASES – (volume 52-2003) *Maneli MH¹, Corrigall AV¹, Davids LM¹, Klump H², Kirsch RE³, Meissner PN¹*
	IDENTIFICATION OF THE SPECIFIC MUTATIONS IN THE CPO GENE RESPONSIBLE FOR GENOTYPE-PHENOTYPE RELATIONSHIP BETWEEN HEREDITARY COPROPORPHYRIA AND HARDEROPORPHYRIA – (volume 52-2003) *Martin C.¹, Gouya L.¹, Da Silva V.¹, Camadro J.M.², Puy H.¹, Deybach J.C.¹*
	CLINICAL AND NUTRITIONAL MANAGEMENT OF ACUTE PORPHYRIAS – (volume 52-2003) *Martin L.¹, Tomassi L.², Parera V.E.³, Batlle A.³*
	EFFECT OF POLYPHENOLS ANTIOXIDANTS ON A MOUSE MODEL OF PROTOPORPHYRIA – (volume 52-2003) *Martinez M.Del C., Afonso S.G., Batlle A.*
	TWO MUTATIONS IN UROPORPHYRINOGEN DECARBOXYLASE (UROD) GENE LEADING TO MILD PHENOTYPE OF HEPATOERYTHROPOIETIC PORPHYRIA (HEP) IN ITALY – (volume 52-2003) *Martinez di Montemuros F¹, Tavazzi D¹, Patti E¹, Galanello R², Fiorelli G¹, Cappellini MD¹*
	MUTATIONAL ANALYSIS FOR ACUTE HEPATIC PORPHYRIAS IN THE UNITED KINGDOM – (volume 52-2003) *Mason NG, Elder GH, Badminton MN*
	MOLECULAR GENETICS OF ERYTHROPOIETIC PORPHYRIA – (volume 52-2003) *Mason NG¹, Khan M¹, Whatley SD¹, Badminton MN¹, Dailey T², Dailey H², Elder GH¹*
	HO1 EXPRESSION AND IMMUNOHISTOCHEMICAL LOCALIZATION IN A MICE MODEL OF CHEMICALLY INDUCE HEPATOCARCINOGENESIS – (volume 52-2003) *Meiss R.¹, Caballero F.A.², Gimenez A.², Batlle A.², Vazquez E.²*
	DUAL PORPHYRIA – PORPHYRIA CUTANEA TARDA AND VARIEGATE PORPHYRIA – IN ARGENTINA – (volume 52-2003) *Melito V., Parera V.E., Rossetti M.V., Batlle A.*
	COPROPORPHYRINOGEN OXIDASE: STRATEGIES FOR UNRAVELING STRUCTURE-FUNCTION RELATIONSHIPS IN ENZYME DEFICIENT IN HEREDITARY COPROPORPHYRIA – (volume 52-2003) *Mikula I.¹, Bodnárová M.¹, Lee D.-S.², Flachsová E.¹, Rosipal R.¹, Zeman J.¹, Moroz L.³, Raman C.S. ², Martásek P.¹*
	DIAGNOSING PORPHYRIA – A CLINICAL AND BIOCHEMICAL SURVEY IN SWISS PATIENTS WITH ACUTE-INTERMITTENT PORPHYRIA – (volume 52-2003) *Minder E*
	DO THE DIFFERENT MUTATIONS IN THE HFE GENE INFLUENCE THE DISTRIBUTION OF THE PORPHYRIN LEVELS IN PORPHYRIA CUTANEA TARDA? – (volume 52-2003) *Morvay M, Koszo F, Dobozy A*
	HEPATIC MITOCHONDRIAL RESPIRATORY CHAIN ENZYME ACTIVITIES CORRELATED WITH EXTENT OF LIVER DAMAGE IN A MURINE MODEL FOR ERYTHROPOIETIC PROTOPORPHYRIA – (volume 52-2003) *Navarro S¹, del Hoyo P¹, Campos Y¹, Abitbol M², Morán-Jiménez MJ¹, García-Bravo M¹, Grau M¹, Montagutelli X², Enríquez de Salamanca R¹, Fontanellas A¹*
	COPROPORPHYRIA IN ARGENTINEAN PATIENTS: GENETIC STUDIES – (volume 52-2003) *Parera V.E.¹, Koole R.², Batlle A.¹, De Rooij F.W.M.²*
	MOLECULAR ANALYSIS OF THE PPOX GENE IN ITALIAN PATIENTS WITH VARIEGATE PORPHYRIA (VP): IDENTIFICATION OF 3 NOVEL MUTATIONS – (volume 52-2003) *Patti E, Martinez di Montemuros F, Di Pierro E, Tavazzi D, Cappellini MD*
	STRUCTURAL BASIS FOR TETRAPYROLE COORDINATION BY UROPORPHYRINOGEN DECARBOXYLASE – (volume 52-2003) *Phillips JD, Whitby FG, Hill CP, Kushner JP*
	PROGNOSTIC VALUE OF SCALING IN ACUTE ATTACK OF AIP – (volume 52-2003) *Pischik E¹, Kauppinen R²*
	IDENTIFICATION OF NINE MUTATIONS INCLUDING THREE NOVEL MUTATIONS AMONG RUSSIAN AIP PATIENTS AND DESCRIPTION OF ONE HOMOZYGOUS PATIENT – (volume 52-2003) *Pischik E¹,², Mehtälä S¹, Smirnova I³, Kazakov V², Kauppinen R¹*
	UPREGULATION OF CYP1B1, CYP3A, TAP1 AND TAP2 IN CULTURED LYMPHOCYTES FROM PATIENTS WITH PORPHYRIA CUTANEA TARDA AFTER IN VITRO-STIMULATION WITH INTERFERON ALPHA – (volume 52-2003) *Poblete-Gutiérrez P¹, Neis MM², Rübben A², Merk HF², Baron JM², Frank J³*
	DEMYSTIFICATION OF CHESTER PORPHYRIA: A NONSENSE MUTATION IN THE PORPHOBILINOGEN DEAMINASE GENE – (volume 52-2003) *Poblete-Gutiérrez P¹, Wiederholt T¹, Martinez-Mir A², Merk HF³, Connor JM⁴, Christiano AM⁵, Frank J⁶*
	ACUTE PORPHYRIA – BUT WHICH ONE? – (volume 52-2003) *Pusztai Á¹, Bor M¹, Székely E¹, Balogh K², Berkes E², Hunyady L², Tasnádi Gy¹*
	AN ALTERNATIVELY-SPLICED 5’UNTRANSLATED EXON IN HUMAN ALAS1 INHIBITS TRANSLATION AND HAEM-REGULATED mRNA DESTABILISATION – (volume 52-2003) *Roberts AG, Llewellyn DH*
	PRO- AND ANTIOXIDANT FACTORS IN ACUTE INTERMITTENT PORPHYRIA – (volume 52-2003) *Rocchi E, Ventura P, Ronzoni A, Rosa MC, Gozzi C, Casalgrandi G*
	EVALUATION OF NEUROTOXICITY OF PORPHYRINOGENIC AGENTS THROUGH DIFFERENT HEME METABOLISM PARAMETERS – (volume 52-2003) *Rodriguez J., Lavandera J., Martinez M. Del C., Gerez E., Batlle A., Buzaleh A.M.*
	OVERT PCT IN A SYMPTOMATIC AIP PATIENT ON HEMODIALYSIS – (volume 52-2003) *Sardh E¹, Harper P², Henrichson A², Möller C³, Andersson D.E.H¹*
	FIRST CLINICAL TRIAL OF I.V. rhPBGD IN HEALTHY SUBJECTS WITH AND WITHOUT DIAGNOSED MANIFEST ACUTE INTERMITTENT PORPHYRIA (AIP) – (volume 52-2003) *Sardh E.¹, Rejkjaer L.², Harper P.³, Andersson D.E.H.¹*
	IDENTIFICATION OF KEY ELEMENTS THAT ARE RESPONSIBLE FOR HEME-MEDIATED INDUCTION OF THE CHICK HEME OXYGENASE-1 GENE – (volume 52-2003) *Shan Y., Lambrecht R.W., Bonkovsky H.L.*
	NON-HEME INDUCTION OF HO-1 DOES NOT APPARENTLY ALTER CELLULAR IRON LEVELS – (volume 52-2003) *Sheftel AD¹, Kim S², Ponka P¹*
	HIGHLY EFFICIENT HEME SYNTHESIS IN ERYTHROID CELLS REQUIRES A DIRECT TRANSFER OF IRON FROM TRANSFERRIN ENDOSOMES TO MITOCHONDRIA – (volume 52-2003) *Sheftel A.D.¹, Zhang A.-S.², Shirihai O.³, Ponka P.¹*
	MOLECULAR CHANGES IN PORPHOBILINOGEN DEAMINASE IN AIP – (volume 52-2003) *Shoolingin-Jordan P.¹, McNeill L.²*
	PARTIAL CHARACTERISATION OF RECOMBINANT MYXOCOCCUS XANTHUS AND HUMAN PROTOPORPHYRINOGEN OXIDASES, AND THEIR PHYLOGENETIC ANALYSES USING PROTEIN SEQUENCES FROM DIVERSE SPECIES – (volume 52-2003) *Siziba KB¹, Corrigall AV¹, Gamieldien J², Maneli MH¹, Kirsch RE³, Meissner PN¹*
	AN AIP FAMILY WITH NO HMBS SEQUENCE VARIANT – (volume 52-2003) *Skadberg O¹, Espetvedt L², Boman H², Sandberg S¹*
	MOLECULAR CHARACTERIZATION OF A SPANISH PATIENT WITH X-LINKED SIDEROBLASTIC ANEMIA – (volume 52-2003) *Solis C.S.¹, Carral A.C.², Perez-Gordillo F.P-G.¹, Lajo A.L.¹*
	ACUTE HEPATIC PORPHYRIAS WITHOUT DETECTABLE GENETIC DEFECTS – (volume 52-2003) *Stauch T.¹, Renz M¹., Seelig H. P¹, Doss M.O.²*
	ESTABLISHMENT OF A NATIONAL REGISTER OF PORPHYRIA PATIENTS – CAN IT BE EXTENDED TO A EUROPEAN REGISTER? – (volume 52-2003) *Stole E., Aarsand A.K., Skadberg O., Tollali , Brun A. , Sandberg S.*
	HFE-MUTATIONS AND RESPONSE TO CHLOROQUINE IN PORPHYRIA CUTANEA TARDA – (volume 52-2003) *Stölzel U¹, Richter M¹, Schuppan D², Doss MO³, Wollina U⁴, Wittekind C⁵, Tannapfel A⁵, Köstler E⁴*
	EFFECTIVENESS OF ALPHA-LIPOIC ACID IN PORPHYRIA CUTANEA TARDA – (volume 52-2003) *Székely E.¹, Tasnádi GY.¹, Pallai ZS.², Kurucz T.², Rapavi E.³, Bor M.¹, Pusztai Á.¹, Blázovics A.³*
	EXTENDED AND REVISED PORPHYRIA DRUG LIST: SCHEME FOR PREVENTIVE MEASURES IN PORPHYRIA PHARMACOTHERAPY – (volume 52-2003) *Thunell S¹, Bjernevik K², Thunell G²*
	A NOVEL MUTATION IN THE FERROCHELATASE GENE AMONG FINNISH EPP PATIENTS – (volume 52-2003) *Timonen K¹, Veikkolainen V², Kauppinen R²*
	LONG-STANDING CHANGES IN THE URINARY PROFILE OF PORPHYRINS AFTER CLINICAL REMISSION OF PORPHYRIA CUTANEA TARDA – (volume 52-2003) *To-Figueras J, Ozalla MD, Herrero C*
	BEING PREPARED, BUT PREPARED FOR WHAT?” A QUALITATIVE STUDY ON THE EXPERIENCE OF GENETIC COUNSELLING AND LIVING WITH A PREDISPOSITION FOR ACUTE INTERMITTENT PORPHYRIA – (volume 52-2003) *Tonder S.L¹, Raaheim M², Skadberg O¹, Sandberg S¹*
	MITOCHONDRIAL TARGETING MECHANISMS OF PROTOPORPHYRINOGEN OXIDASE: IDENTIFICATION AND CHARACTERIZATION OF INTERNAL TARGETING SEQUENCES – (volume 52-2003) *von und zu Fraunberg M, Kauppinen R*
	VARIEGATE PORPHYRIA IN SOUTH AFRICA: A POPULATION-BASED STUDY TO DETERMINE THE FREQUENCY OF THE FOUNDER GENE MUTATION (R59W) – (volume 52-2003) *Warnich L, Koegelenberg AJ*
	SHORT-TERM AND LONG-TERM WITHIN-SUBJECT BIOLOGICAL VARIATION OF URINARY ALA, PBG AND PORPHYRINS IN ACUTE INTERMITTENT PORPHYRIA – (South Africa Congress, Cape Town-2005) *Aarsand AK1, Petersen PH2, Sandberg S1*
	HUMAN X-LINKED SIDEROBLASTIC ANAEMIA (XLSA) CAUSING MUTATIONS EXPLAINED BY THE CRYSTAL STRUCTURE OF 5-AMINOLEVULINATE SYNTHASE FROM RHODOBACTER CAPSULATUS – (South Africa Congress, Cape Town-2005) *I. Astner1, J.O. Schulze1, W.-D. Schubert1, D. Jahn2, D.W. Heinz1*
	UROD R193P – A NORWEGIAN FOUNDER MUTATION FOR PORPHYRIA CUTANEA TARDA – (South Africa Congress, Cape Town-2005) *Boman H1,2, Aarsand AK2, Sandberg S2*
	PORPHYRIA DIAGNOSIS – PROBLEMS AND PITFALLS – (South Africa Congress, Cape Town-2005) *Sylvia S. Bottomley*
	RENAL CLEARANCE OF PLASMA PORPHYRINS IN PCT PATIENTS – (South Africa Congress, Cape Town-2005) *Axel Brock and Erland J. Erlandsen*
	EFFECT OF HIGH LEVELS OF HEMIN ON THE ANTIOXIDANT DEFENSE SYSTEM OF TRYPANOSOMA CRUZI – (South Africa Congress, Cape Town-2005) *Alejandra Ciccarelli, Elisa Lombardo, Lidia Araujo & Alcira Batlle*
	ACTIVE SITE OF HUMAN FERROCHELATASE – (South Africa Congress, Cape Town-2005) *H.A. Dailey, C.-K. Wu, W.N. Missaoui, P. Horanyi, B.-C. Wang, J. Rose, and T.A. Dailey*
	THE IRISH NATIONAL PORPHYRIA DATABASE – (South Africa Congress, Cape Town-2005) *Darby C1, Sullivan G2, Rennison A3, Marr R3 Brazil N1, Breen E1, Crowley VEF4, Gannon P4*
	REVIEW OF PORPHYRIA IN THE REPUBLIC OF IRELAND – (South Africa Congress, Cape Town-2005) *C Darby, RR O’Moore and VEF Crowley*
	ANCESTRAL FOUNDER OF MUTATION R116W IN THE PORPHOBILINOGEN DEAMINASE GENE AMONG DUTCH ACUTE INTERMITTENT PORPHYRIA PATIENTS – (South Africa Congress, Cape Town-2005) *F.W.M. de Rooij, F.G. Kavelaars, H. Koole-Lesuis, J.H.P. Wilson*
	AUTOSOMAL RECESSIVE ERYTHROPOIETIC PROTOPORPHYRIA WITHOUT IVS3-48C IN TWO BROTHERS WITH LIVER DYSFUNCTION IN EARLY CHILDHOOD – (South Africa Congress, Cape Town-2005) *F.W.M. de Rooij, K. Munte, A. Edixhoven, R. Koole, J.H.P. Wilson*
	EUROPEAN PORPHYRIA INITIATIVE (EPI): A PLATFORM TO DEVELOP A COMMON APPROACH TO THE MANAGEMENT OF PORPHYRIAS AND TO PROMOTE RESEARCH IN THE FIELD – (South Africa Congress, Cape Town-2005) *Jean-Charles Deybach1, Mike Badminton2, Hervé Puy1, Sverre Sandberg3, Jorge Frank4, Pauline Harper5, Pavel Martasek6, Elisabeth Minder7, Samantha Parker8, Stig Thunell5 George Elder2*
	ALA-PDT SENSITIVITY OF CELL LINES RESISTANT TO NITRIC OXIDE CYTOTOXICITY – (South Africa Congress, Cape Town-2005) *Gabriela Divenosa, Adriana Casas, Christian Perotti, Haydee Fukuda & Alcira Batlle*
	PORPHYRIA CONSULTATION: FORTY YEAR EXPERIENCE IN GERMANY – (South Africa Congress, Cape Town-2005) *Manfred O. Doss1, Ulrich Groß1, Thomas Stauch2*
	ERYTHROPOIETIC PORPHYRIA AND HAEMATOLOGICAL MALIGNANCY – (South Africa Congress, Cape Town-2005) *Elder GH, Whatley SD, Woolf J, Mason NG, 1Masters G, Badminton MN*
	QUANTITATION OF PLASMA PORPHYRINS:VALIDATION OF LIQUID-LIQUID EXTRACTION METHOD – (South Africa Congress, Cape Town-2005) *Erland J. Erlandsen, Peer R Mortensen, Bente Warshawsky, Axel Brock*
	VARIEGATE PORPHYRIA IN ARGENTINEAN POPULATION. CHARACTERIZARION OF THE MOLECULAR DEFECT – (South Africa Congress, Cape Town-2005) *Mariela Ferreira Gomes, Victoria Parera, Alcira Batlle & Maria Victoria Rossetti*
	EFFECTS OF REPEATED ADMINISTRATION WITH CP-55,940, A CANNABINOID CB1 RECEPTOR AGONIST ON THE METABOLISM OF THE HEPATIC HEME – (South Africa Congress, Cape Town-2005) *María García-Bravo1, Antonio Fontanellas1, Ana María Buzaleh2, Manuel Méndez1, José María Oliva1, Alcira Batlle2, Tomas Palomo1, Rafael Enríquez de Salamanca1*
	CONTRIBUTION OF A COMMON SINGLE SNP TO THE GENETIC PREDISPOSITION TO ERYTHROPOIETIC PROTOPORPHYRIA – (South Africa Congress, Cape Town-2005) Laurent Gouya, Caroline Martin-Schmitt, Anne-Marie Robreau, Saïd Lyoumi, Vasco Da Silva, Hervé Puy, Jean-Charles Deybach*
	CONGENITAL ERYTHROPOIETIC PROTOPORPHYRIA: APPARENT AMELIORATION OF SYMPTOMS AND SUCCESSFUL PREGNANCY – (South Africa Congress, Cape Town-2005) *Hallai N1, Anstey AV1, Williams J2, Mendelsohn S3, Mallick S2, Badminton MN*
	PLASMA AND URINARY HEME PRECURSOR PATTERNS AFTER I.V. RHPBGD ADMINISTRATION TO ASYMPTOMATIC PBGD-DEFICIENT SUBJECTS WITH HIGH EXCRETION OF URINARY PBG – (South Africa Congress, Cape Town-2005) Harper P, #Sardh E, Henrichson A, Rejkjær L, #Andersson DEH
	BIOCHEMICAL AND GENETIC CHARACTERIZATION OF FOUR CASES OF HEREDITARY COPROPORPHYRIA IN SPAIN – (South Africa Congress, Cape Town-2005) **Carmen Herrero , Jordi To-Figueras , Celia Badenas , Maria T Enríquez (), Sonia Segura , Concepción Alvarez (), Montserrat Milà , Marius Lecha*
	UNITED KINGDOM PROSPECTIVE CLINICOPATHOLOGICAL STUDY ON ERYTHROPOIETIC PROTOPORPHYRIA – (South Africa Congress, Cape Town-2005) SA Holme, AV Anstey, NM Badminton, GH Elder
	UNITED KINGDOM PROSPECTIVE STUDY ON ERYTHROPOIETIC PROTOPORPHYRIA: QUALITY OF LIFE ASSESSMENT – (South Africa Congress, Cape Town-2005) SA Holme, AV Anstey, NM Badminton, GH Elder
	DOES SCREENING FOR HEPATOCELLULAR CARCINOMA BENEFIT PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA? – (South Africa Congress, Cape Town-2005) *M. Holmgren and C. Andersson*
	STRUCTURE AND FUNCTION OF HEME BIOSYNTHETIC ENZYMES – (South Africa Congress, Cape Town-2005) *Martina Jahn, Ilka Heinemann & Dieter Jahn*
	ADENOVIRAL-MEDIATED EXPRESSION OF PORPHOBILINOGEN DEAMINASE IN LIVER RESTORES THE METABOLIC DEFECT IN A MOUSE MODEL OF ACUTE INTERMITTENT PORPHYRIA – (South Africa Congress, Cape Town-2005) **Johansson A1,, Nowak G2, Möller C3, Blomberg P4, Harper P1***
	INVESTIGATION OF THE EFFECTS OF AN AROMATIC RESIDUE AT CODON 59 OF HUMAN PROTOPORPHYRINOGEN OXIDASE – (South Africa Congress, Cape Town-2005) *A Josias, AV Corrigall, RE Kirsch, PN Meissner*
	NOVEL 19 BP DELETION OF EXON 15 IN THE PBGD GENE AND NORMAL ERYTROCYTE PORPHOBILINOGEN ACTIVITY IN A PATIENT WITH ACUTE INTERMITTENT PORPHYRIA – (South Africa Congress, Cape Town-2005) *R.Kauppinen, A.Yrjönen, E.Pishick*
	HOMOZYGOUS VARIEGATE PORPHYRIA PATIENT WITH SEVERE IGA NEPHROPATHY – (South Africa Congress, Cape Town-2005) *R.Kauppinen, K Timonen*
	SPECTRUM OF MUTATIONS IN THE FERROCHELATASE GENE IDENTIFIED AMONG FINNISH ERYTRHROPOIETIC PROTOPORPHYRIA PATIENTS INCLUDING A NOVEL SPLICING DEFECT – (South Africa Congress, Cape Town-2005) *R.Kauppinen, Kaisa Timonen*
	LIVER BIOPSY MORPHOLOGY AND HFE-GENE STATUS IN CUTANEOUS PORPHYRIA (PCT) – (South Africa Congress, Cape Town-2005) *E. Köstler, U. Stölzel, G. Sell, U. Wollina*
	INVOLVEMENT OF FASE I DRUG METABOLIZING SYSTEM IN THE METABOLIZATION OF PORPHYRINOGENIC AGENTS IN BRAIN. A COMPARATIVE STUDY IN LIVER AND KIDNEY – (South Africa Congress, Cape Town-2005) *Jimena Lavandera, Alcira Batlle & Ana Maria Buzaleh*
	INSULIN AND VANADATE ACTION ON HEME BIOSYNTHESIS GENES TRANSCRIPTION IN DIABETIC MICE – (South Africa Congress, Cape Town-2005) *Oliveri Leda, Vazquez Elba, Batlle Alcira, Gerez Esther*
	A CASE OF ALAD PORPHYRIA IN NORTH AMERICA: RESPONSE TO HEMIN THERAPY – (South Africa Congress, Cape Town-2005) *1Chul Lee, 1Karl E. Anderson, 2Shigeru Sassa and 3Reiko Akagi*
	THE 1.58 Å CRYSTAL STRUCTURE OF HUMAN COPROPORPHYRINOGEN OXIDASE REVEALS THE STRUCTURAL BASIS OF HEREDITARY COPROPORPHYRIA – (South Africa Congress, Cape Town-2005) **Dong-Sun Lee, Eva Flachsová‡, Michaela Bodnárová‡, Borries Demeler†, Pavel Martásek‡ & C. S. Raman§**
	EXPERIMENTAL PROTOPORPHYRIA: EFFECT OF BILE ACIDS ON GRISEOFULVIN-INDUCED HEPATIC DAMAGE – (South Africa Congress, Cape Town-2005) *Martinez, María. del Carmen., Batlle, Alcira & Afonso, Susana*
	FREQUENCY OF INTRON 1 C/A POLYMORPHISM OF THE CYP1A2 IN SPANISH PATIENTS WITH PORPHYRIA CUTANEA TARDA – (South Africa Congress, Cape Town-2005) María Martínez-Fresno (1), Nuno Henriques-Gil (1), María-Concepción Garrido (2), Teresa Perucho-Alcalde (1), María García-Bravo (2), Manuel Méndez (2), Antonio Fontanellas (2), Rafael Enríquez de Salamanca (2)
	EFFECTS OF THE HERBICIDE ACIFLUORFEN IN THE R59W PROTOPORPHYRINOGEN OXIDASE MUTANT MOUSE MODEL FOR VARIEGATE PORPHYRIA – (South Africa Congress, Cape Town-2005) *A Medlock, R Meldau, A Corrigall, A Josias, R Hift, Pete Meissner*
	MOLECULAR HETEROGENEITY OF PORPHYRIA CUTANEA TARDA IN SPAIN: IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF MUTATIONS IN THE UROPORPHYRINOGEN DECARBOXYLASE GENE – (South Africa Congress, Cape Town-2005) Manuel Mendez1, Pamela Poblete-Gutiérrez2, Jaime Cruz-Rojo 1, María García-Bravo1 María-Concepción Garrido1, Rafael Enríquez de Salamanca1, Jorge Frank2, Antonio Fontanellas1
	ATYPICAL RED CELL INCLUSIONS IN A PATIENT WITH CONGENITAL ERYTHROPOIETIC PORPHYRIA – (South Africa Congress, Cape Town-2005) **A Merino, M Rozman, C Herrero, J To-Figueras, A Ordinas*
	STUDY OF THE OLIGOMERIC STATUS OF COPROPORPHYRINOGEN OXIDASE (CPO) USING ANALYTICAL ULTRACENTRIFUGATION (AU) – (South Africa Congress, Cape Town-2005) *Ivan Mikula1, Borries Demeler2 and Pavel Martásek1*
	DISEQUILIBRIUM IN EXPRESSION OF APOPTOSIS FACTORS BETWEEN SYMPTOMATIC AND ASYMPTOMATIC INDIVIDUALS WITH ACUTE INTERMITTENT PORPHYRIA – (South Africa Congress, Cape Town-2005) *Elisabeth I. Minder, Anna-Elisabeth Minder and Xiaoye Schneider-Yin*
	CONCURRENT UPREGULATION OF HAEM OXYGENASE 1 AND CYTOCHROME P450 2A5: POSSIBLE ROLE OF Nrf2 AND hnRNP A1 – (South Africa Congress, Cape Town-2005) *Michael R. Moore1, Aedah A. Bakar1, Matti A Lang2*
	PRODUCTION AND CHARACTERIZATION OF ERYTHROPOIETIC PROTOPORPHYRIC HETERODIMERIC FERROCHELATASES – (South Africa Congress, Cape Town-2005) *Wided Najahi-Missaoui and Harry A. Dailey*
	THE MANAGEMENT OF PORPHYRIC PATIENTS WITH MALIGNANT DISEASE: A REVIEW OF THE LITERATURE AND RECOMMENDATIONS FOR THE FUTURE – (South Africa Congress, Cape Town-2005) *Carlo Palmieri1, David M.Vigushin1, Timothy J Peters2*
	CONGENITAL ERYTHROPOIETIC PORPHYRIA IN ARGENTINA – (South Africa Congress, Cape Town-2005) *Victoria Parera, Maria Victoria Rossetti, Viviana Melito & Alcira Batlle*
	CHARACTERISATION OF ERYTHROPOIETIC PROTOPORPHYRIA IN SOUTH AFRICA – (South Africa Congress, Cape Town-2005) *Michelle Parker , Anne V. Corrigall and Peter N. Meissner*
	HEPATIC GENE EXPRESSION PROFILING IN HEPATITIC C VIRUS INFECTED PATIENTS WITH PORPHYRIA CUTANEA TARDA (PCT) – (South Africa Congress, Cape Town-2005) *John D. Phillips1, Maria W. Smith2, Michael Katze2 and James P. Kushner1*
	NATURAL COURSE OF AN ACUTE ATTACK IN ACUTE INTERMITTENT PORPHYRIA – (South Africa Congress, Cape Town-2005) *E.Pishick, A. Yrjönen, R.Kauppinen*
	THE DRUG DATABASE FOR ACUTE PORPHYRIA – (South Africa Congress, Cape Town-2005) Erik Pomp , Stig Thunell § and Atle Brun
	DRUG PORPHYRINOGENICITY MONOGRAPHS IN THE DRUG DATABASE FOR ACUTE PORPHYRIA – (South Africa Congress, Cape Town-2005) Erik Pomp , Stig Thunell § and Atle Brun
	HAEM-MEDIATED DESTABILISATION OF HUMAN ALAS1 mRNA – (South Africa Congress, Cape Town-2005) *Sadie J. Redding, AG Roberts and D Llewellyn*
	URINARY COPROPORPHYRIN ISOMERS IN CONGENITAL AND ACQUIRED LIVER CHOLESTASIS – (South Africa Congress, Cape Town-2005) *E. Rocchi1, P. Ventura2, G. Casalgrandi1, S. Marchini2*
	5-AMINOLEVULINIC ACID ALTERS THE ANTIOXIDANT ENZYME SYSTEM IN MICE BRAIN – (South Africa Congress, Cape Town-2005) *Jorge Rodriguez, Alcira Batlle & Ana Maria Buzaleh*
	CLINICAL, BIOCHEMICAL AND PATHOHISTOLOGICAL ASPECTS IN 12 PATIENTS WITH ACUTE PORPHYRIA AND HEPATOCELLULAR CANCER – (South Africa Congress, Cape Town-2005) **Sardh E#, Harper P, Andersson DEH#***
	RELIABLE BIOCHEMICAL CRITERIA FOR CONFIRMING AN ACUTE ATTACK OF NEUROPORPHYRIA – (South Africa Congress, Cape Town-2005) *N. Schoenfeld1,2 and R. Mamet1*
	KISS AND RUN: THE ROUTE OF IRON FROM ENDOSOMES TO MITOCHONDRIA CAN BYPASS THE CYTOSOL IN HEMOGLOBIN-PRODUCING CELLS – (South Africa Congress, Cape Town-2005) **Alex Sheftel [1], An-Sheng Zhang[1,2], Orian Shirihai [3], Prem Ponka [1]***
	STRUCTURAL ASPECTS OF HUMAN PBG DEAMINASE IN RELATION TO ACUTE INTERMITTENT PORPHYRIA – (South Africa Congress, Cape Town-2005) *Peter Shoolingin-Jordan, Luke McNeill, Abeer Al Dbass, Raj Gill, Steve Wood, Fiyaz Mohammed, Julie Mosley and Danica Butler*
	MOUSE MODELS FOR STUDYING THE EFFECTS OF ALCOHOL AND ASCORBIC ACID IN PCT – (South Africa Congress, Cape Town-2005) *Peter R Sinclair, Nadia Gorman, Heidi W. Trask, Juliana G. Szakacs, George H. Elder, Dominic Balestra, Nicholas J. Jacobs, Judith M. Jacobs, Jacqueline F. Sinclair , and Glenn S. Gerhard*
	VARIEGATE PORPHYRIA VERSUS PCT AND ACNE: PITFALLS IN DIAGNOSIS AND TREATMENT – (South Africa Congress, Cape Town-2005) *Th. Stauch, M. Doss-Frank and M. O. Doss*
	THE NORWEGIAN PORPHYRIA REGISTER – (South Africa Congress, Cape Town-2005) *Stoele E, Johannessen RA, Aarsand AK, Brun A and Sandberg S*
	HFE-MUTATIONS, IRON, HEPATITIS C, AUTOIMMUNITY, LIVER DAMAGE AND THERAPEUTIC RESPONSE IN PORPHYRIA CUTANEA TARDA IN GERMANY – (South Africa Congress, Cape Town-2005) *Ulrich Stölzel, MD (1); Erich Köstler, MD (2); Detlef Schuppan, MD (3); Matthias Richter, MD (1); Manfred O. Doss, MD (4); Uwe Wollina, MD (2)*
	INDIVIDUAL REFERENCE VALUES OF URINARY ALA, PBG AND PORPHYRINS IN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA – (South Africa Congress, Cape Town-2005) *Jordi To-Figueras, Gregori Casals, Carlos Muñoz, Cristina Carrera, Carmen Herrero*
	EXPERIENCE OF GENETIC COUNSELING IN NORWAY – (South Africa Congress, Cape Town-2005) **Siv Lisbeth Tønder, Helge Boman, Øyvind Skadberg and Sverre Sandberg***
	MUTATION SCREENING IN NEWLY (2004) DIAGNOZED PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA FROM CZECH AND SLOVAK REPUBLICS – (South Africa Congress, Cape Town-2005) *Dana Ulbrichova, Matous Hrdinka, Eva Flachsová, Ivan Mikula, Michaela Bodnarova, Jana Prochazkova, Jana Saligova1, Eva Silhanova2, Hana Halamkova3, Jiri Zeman, Pavel Martasek*
	CHARACTERISATION OF MITOCHONDRIAL TARGETING OF WILD TYPE AND MUTANT (L88Q) HUMAN COPROPORPHYRINOGEN OXIDASE – (South Africa Congress, Cape Town-2005) *Van Der Merwe D, Roberts AG, Badminton MN*
	FOUR CASES OF CHOLESTATIC LIVER FAILURE IN ERYTHROPOIETIC PROTOPORPHYRIA – VARYING CLINICAL COURSE AND EXAMPLE OF EFFECTIVE MEDICAL TREATMENT – (South Africa Congress, Cape Town-2005) *Staffan Wahlin1, Ulrika Broomé1, Pauline Harper2*
	MUTATION DETECTION IN THE FECH GENE – (South Africa Congress, Cape Town-2005) *Whatley SD, Woods L, Mason NG, Roberts AG, Badminton MN*
	DRUG PRESCRIPTION IN PATIENTS WITH CRIGLER-NAJJAR SYNDROME – (South Africa Congress, Cape Town-2005) *J.H.P. Wilson, M. Sinaasappel*
	PREGNANCY IN CRIGLER-NAJJAR SYNDROME – (South Africa Congress, Cape Town-2005) *J.H.P. Wilson, M. Sinaasappel, F.K. Lotgering*
	THE DIAGNOSIS OF ACUTE HEPATIC PORPHYRIA BY PLASMA ALA, PBG, FLUORESCENCE SCANNING AND ENZYME ASSAYS, USING DNA ANALYSIS AS REFERENCE – (South Africa Congress, Cape Town-2005) *J.H.P. Wilson, A. Edixhoven, R. Koole, F.W.M. de Rooij*
	A TRUNCATED FORM OF HEME OXYGENASE-1 IS FOUND IN THE NUCLEUS OF CULTURED CELLS IN RESPONSE TO INCREASES IN INTRACELLULAR HEME – (South Africa Congress, Cape Town-2005) **Guang Yang, Ph.D., Qing Lin, Ph.D., Yi-Hao Weng, M.D.#. Kimberly Rish, M.S., Ann Smith, Ph.D. * and Phyllis A. Dennery, M.D.***
	5-AMINOLEVULINATE SYNTHASE SCAFFOLD AND CONVERSION INTO A MORE ACTIVE ENZYME – (South Africa Congress, Cape Town-2005) *J.-S. Zhang, G. A. Hunter and G. C. Ferreira*

	Print entire Abstract book 2005 >>
	Print entire Abstract book 2003 >>
	Print selected Abstract(s) >>

PDF files require Adobe Acrobat Reader; click here to download this free program

<< New Search